HAWAII BIOTECH, INC. — Department of Health and Human Services SBIR Phase II: 105
HAWAII BIOTECH, INC. — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $2,997,218
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- Topic
- 105
- Solicitation
- PHS-2022-1
- NAICS
- —
- Place of performance
- HI
- Period
- —
Description
The contract supports the development of TLR4 agonist within an oil-in-water emulsion as a vaccine adjuvant. The adjuvant development activities are being conducted within the context of vaccines to protect against West Nile virus infection.